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Sun exposure has now been established as the most important avoidable cause of nonmelanoma skin cancer (NMSC) and melanoma. With specific
reference to melanoma, there are several key issues that remain to be resolved. These include definition of the action spectrum, the importance of
systemic effects of sun exposure, whether a tan is protective, the risk of tanning booth exposures, and the efficacy of sunscreens. Also the role, if
any, of sun exposure in noncutaneous malignancies remains to be established. Melanoma incidence and mortality have increased dramatically over
the past several decades, but these increases have now slowed, and for mortality among those 15 to 45 years of age, decreasing rates are now
observed. Improving the coverage of the Surveillance, Epidemiology, and End Results (SEER) registries by requiring pathology laboratories in
non-SEER areas to report cancers among SEER area residents will allow correct interpretation of these trends in the future at minimal cost. The
available data on trends in NMSC incidence and mortality are suboptimal but suggest a pattern of declining mortality despite increasing incidence.
Trends in NMSC morbidity have not been defined. Establishing NMSC registries in a few diverse sentinel areas would allow more reliable inference
and monitoring. Techniques are being developed for reducing sun exposures and increasing early detection of skin cancers in the general
population, but improved monitoring of incidence, mortality, and morbidity is required to monitor the effects of current and future ozone depletion
and to evaluate prevention and early detection measures. - Environ Health Perspect 103(Suppl 8):251-254 (1995)
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Introduction
Ultraviolet radiation exposure has a variety
ofadverse health effects, including both
malignancies and nonmalignant disorders
of the skin and other organs. The most
common ultraviolet-related malignancies
are nonmelanoma skin cancers (NMSCs),
which, in the United States, are approxi-
mately equal in incidence to all other
malignancies combined (1). NMSC con-
ventionally includes basal cell carcinoma
(BCC) and squamous cell carcinoma
(SCC); the former is more common, but
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the latter is more aggressive and more
commonlyleads to death (2).
Malignant melanoma is less common
than either BCC or SCC, but is ofgreater
public health concern. It is not uncom-
mon; indeed, it is more common than any
noncutaneous malignancy in the 25- to 29-
year-old age group, and its incidence is
increasing faster than any noncutaneous
cancer site among men and, with the
exception oflung cancer, among women
(3). More significantly, it is responsible for
approximately 7000 deaths per year, which
is far greater than the mortality associated
with NMSC (4).
There are nonneoplastic disorders and
other cutaneous malignancies that have
been linked to ultraviolet exposure, indud-
ing atypical fibroxanthoma (5); other der-
matoses (6,7); immune dysfunction (8);
and ocular disease, particularly cataracts
(9,10), but these will not be further
discussed here.
The Link
A vast array of epidemiologic and other
investigations allows us to conclude that
sun exposure causes skin cancer ofeach of
the three most common types: BCC, SCC,
and melanoma. Melanoma has been more
dosely linked to intense, intermittent expo-
sures to the sun, whereas NMSC is more
closely linked to cumulative exposure.
However, this distinction is far from abso-
lute; in populations with high ultraviolet
exposure, cumulative exposure may be
closely linked to melanoma (11,12). Sun
exposures early in life, especially in child-
hood and adolescence, are particularly asso-
ciated with melanoma, although such
exposures are likely to play an important
role in BCC and SCC as well (13,14).
Studies ofspecial contexts (human models)
have been informative (15). Even in the
context offamilial melanoma and ofxero-
derma pigmentosum, the very limited
available evidence supports the link
between sun exposure and cutaneous
malignancy (16-20).
Unresolved Issues
Ultraviolet light is not a single entity but
rather a spectrum ofelectromagnetic radia-
tion that includes a broad band ofwave-
lengths. Convention has defined ultraviolet
A (UVA) to include those wavelengths
longer than 320 nm, ultraviolet B (UVB)
those in the range of280 to 320 nm, and
ultraviolet C (UVC) those below 280 nm.
UVC does not penetrate the earth's atmos-
phere, so human exposure is a result of
exposures to artificial sources. UVB is
responsible for sunburns and is the range
most strongly blocked by common sun-
screens. UVA, unlike UVB, varies relatively
little with solar elevation, and hence with
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the time ofday or season ofthe year. The
various recommendations for skin cancer
prevention that have been offered to the
general public differ in their relative effec-
tiveness for different ultraviolet wave-
lengths. For example, clothing typically
reduces ultraviolet exposure to the skin
more uniformly across the spectrum than
avoiding the midday sun, which will
disproportionately reduce UVB exposure.
A key issue for each ofthe three com-
mon types of skin cancers is, therefore,
documentation of the action spectrum
(i.e., the relation between carcinogenesis
and wavelength). Epidemiologic research
has not been able to document an action
spectrum for any of these malignancies.
Fortunately, there are well-established ani-
mal models for SCC, which have been
used to estimate the action spectrum.
These studies have documented maximal
carcinogenicity in the UVB region (21,22).
Animal models have been proposed for
melanoma; some action spectrum data
have been derived from a fish model,
which suggests substantial carcinogenic
potential for UVA, but the relevance of
these experiments to the disorder in human
remains to be clarified (23-26).
A second key unresolved issue is the
relative importance oflocal versus systemic
effects of sun exposure. The majority of
BCCs and of SCCs occur on the chroni-
cally sun-exposed skin ofthe face, although
most melanomas occur elsewhere on the
body, and the evidence from case-control
studies regarding melanomas that occur at
common locations has not demonstrated
associations between location ofsun expo-
sure and location ofthe melanoma (27-29).
Among patients with xeroderma pigmento-
sum, NMSCs are more concentrated on
the face than melanomas (30). On the
other hand, the most sun-protected areas
of the body do have the lowest incidence
per unit surface area ofmelanoma (12). It
is also clear from the laboratory that both
local and systemic effects of ultraviolet
exposure exist (8,31). For anogenital or
vaginal melanoma, where direct sun expo-
sure is not involved, populations with
greater presumed cutaneous sun exposure
because they live nearer to equatorial lati-
tudes do not have a higher incidence
(32,33). Hence, epidemiologic evidence
has not be able to completely resolve the
relative importance of a systemic effect, if
any, of sun exposure on the genesis of
melanoma, although direct exposure
appears to be important.
A third key unresolved issue is whether
a tan (facultative pigmentation) protects
against melanoma for some groups. It is
dear that individuals with darker untanned
skin color (constitutive pigmentation) are at
substantially lower risk of melanoma.
Suntans also protect against sunburn,
which is associated with melanoma risk
(34). There have now been several studies
published that suggest that frequent sun
exposure may be associated with lower rela-
tive risks among those who tan readily (pre-
sumably as a result of their developing a
photoprotective tan) compared to the rela-
tive risks ofsimilar exposures among those
who are more sun sensitive and less capable
of tanning; however, this hypothesis
remains controversial (28,35-38).
The risk ofmelanoma associated with
exposure to artificial sources ofultraviolet
is also uncertain. Several, but not all,
studies of this question have noted an
association between these exposures and
melanoma risk (39,40).
The fourth issue is the efficacy ofsun-
screens for melanoma prevention. We
know from trials among human popula-
tions that conventional sunscreens are
efficacious for preventing sunburns and for
reducing the multiplicity of actinic ker-
atoses (41). However, we have no direct
evidence, from either animal models or
human studies, about their efficacy for
melanoma prevention. Indeed, one publi-
cation has even suggested that sunscreen
use causes melanoma and was responsible
for the sharp rise in melanoma incidence
observed over the last several decades (42),
although this suggestion is not supported
by anysubstantial evidence and does not fit
with our current understanding of the
genesis ofmelanoma. Hence, although we
presume that sunscreens are effective, we
do not have proof and cannot presently
quantify their effectiveness.
Finally, the role ofsun exposure, ifany,
in noncutaneous malignancies has not been
established. A number of cancer sites
exhibit a latitude gradient that is presently
unexplained. However, there is no strong
evidence to support a role for the sun in
the etiology ofany noncutaneous malig-
nancy, except perhaps as a cause ofocular
malignancy due to direct exposure.
These halfdozen issues represent key
areas ofuncertainty in our understanding
ofthe link between the ultraviolet radia-
tion and cutaneous malignancy. The list is
not comprehensive, and it focuses on those
issues that pertain to melanoma. The un-
certainties stand out against a background
ofgeneral acceptance ofsun exposure as
the major avoidable cause of melanoma,
accounting for over 90% ofthe melanomas
in the United States and about two-thirds
ofthe melanomas worldwide (43).
CurrentTrends-Melanoma
Age-adjusted mortality rates for malignant
melanoma in the United States have been
increasing consistently over many decades
and continued to increase throughout the
1980s. This increase occurred among
whites but not blacks. In 1990 the rate
among whites was 2.5 per 100,000 indi-
viduals per year, and among blacks 0.4 per
100,000 individuals per year. Age-adjusted
melanoma incidence has also been increas-
ing among whites since at least the 1930s,
and is now over 10 times more common
than it was. In recent years, the incidence
has been more than 12 times higher among
whites (12.0 per 100,000 individuals per
year) than among blacks (0.9 per 100,000
individuals peryear) (3).
Some stratospheric ozone depletion has
occurred since the 1930s, but that appears
to have contributed little to the present
increase in melanoma because the magni-
tude ofthe depletion has been quite mod-
est. Rather, the observed increases in both
incidence and mortality appear to be most
closely linked to behavioral and lifestyle
factors, including the popularity oftanning
and the corresponding unpopularity ofpale
skin among whites, the changing styles of
dress in general and recreational (particu-
larly beach) attire in particular, the increase
in leisure time during these decades, and
the increased accessibility of recreation in
areas of intense sunlight because of the
widespread availability ofautomobiles and
air travel.
Past trends will not necessarily con-
tinue, however, and recent data provide
evidence that these trends may indeed
change. Age-specific mortality data were
evaluated for the years 1969 through 1990
for whites in the United States. Despite an
overall increase in mortality during this
period, the youngest age groups (ages
15-29 years and 30-44 years) experienced
declines in mortality for both genders
(44). These data have been used to project
an actual decline in age-adjusted melanoma
mortality in the second decade ofthe 21st
century (45,46). Without understanding
the cause of the current trends, however,
predictions regarding future trends must be
viewed cautiously.
It is clear that case fatality from mela-
noma has dedined substantially despite the
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absence ofmajor therapeutic advances. This
decline undoubtedly played an important
role in the observed changes in mortality.
However, the role of changes in incidence
remains unclear.
The primary source ofmelanoma inci-
dence data in the United States is the
SEER Program of the National Cancer
Institute. Despite the general excellence of
the SEER program, it has encountered
difficulties in recent years in attaining com-
plete registration ofmelanoma (47-50). As
a result, the observed pattern in the SEER
data of relatively stable incidence rates
must be interpreted with care.
Among these issues, out-of-area diagno-
sis may be the most difficult problem for a
disorder such as melanoma, which is cured
in the majority of patients and frequently
diagnosed and cured in an outpatient set-
ting. Dermatologists frequently biopsy a
skin lesion to diagnose melanoma. They
typically excise the melanoma in their
offices, and then mail the specimen to a
pathology laboratory. If the pathology lab-
oratory is in the cancer registry area and
the registry is functioning properly, these
cases will be registered. However, the
pathology laboratory sometimes is located
outside the registry area, in which case the
cancer registry may miss the case entirely.
This trend toward outpatient and out-of-
area diagnosis threatens the usefulness of
the existing system of cancer registries in
guiding policy, practice, and research for
cancers that are commonly diagnosed
among outpatients.
Were a national cancer registry to be
developed, this problem would largely dis-
appear. However, much less expensive alter-
natives are available. It would be sufficient
to require that pathology laboratories in
non-SEER areas record their patients' zip
codes and report the cancers that occur
among SEER area residents. Effort and
expense involved in this approach would be
minimal, yet would be essential to guaran-
tee the integrity of the SEER registry data
in the current changing health care climate.
Current Trends NMSC
NMSCs as a group have a case fatality rate of
less than 1%; however, this low percentage
still results in over a thousand deaths annu-
ally because of the frequency with which
these malignancies occur. Unfortunately,
NMSC mortality is poorly tracked by our
vital statistics in the United States. We
recently investigated over 100 deaths
among residents ofRhode Island that were
attributed to NMSC by vital statistics data.
Over halfofthese deaths were misclassified,
and the majority ofmisclassified cases were
instances of squamous carcinoma of the
mucosal surfaces in the head and neck.
These cases were described on death certi-
ficates as dying from squamous or epider-
moid carcinoma ofthe head and neck and
the coding rules assigned them the code
173.4, which incorrectly classified the cause
ofdeath as NMSCs. Therefore, to obtain
accurate mortality estimates for NMSC, it is
recommended that the International
Classification ofDiseases (ICD) coding sys-
tem be modified to exclude squamous cell
carcinoma ofthe head and neck and other
similar terms from code 173.4 (the NMSCs
ofthe scalp and neck).
Extrapolation from our observations to
the existing nationwide statistics regarding
NMSC mortality suggested that the mor-
tality rate from this cause has indeed been
declining over the past two decades. The
age-adjusted rates for whites and blacks for
1987 to 1988, which is the most recent
published data, were 0.5 and 0.3 per
100,000 individuals per year, and the rate
among men was substantially higher than
that among women (51).
Data regarding the incidence of
NMSC is also quite limited compared
with corresponding data on melanoma.
The only available data from diverse areas
of the United States are from a 17-year-
old study ofthe National Cancer Institute.
Since sun exposure accounts for the vast
majority ofNMSCs as well as melanomas,
one would expect NMSC incidence to be
increasing substantially in recent decades.
This expectation was confirmed by data
from the British Columbia Cancer Registry
and from Kaiser-Permanente data from
Oregon. Extrapolation of these trends to
the entire U.S. population suggested that
900,000 to 1,200,000 persons would be
diagnosed with NMSC nationwide in 1994
(1). Approximately this many people are
diagnosed with all other types of cancer
combined. This projection may be subject
to considerable error, but it is presently the
best available estimate because NMSC is
not included in standard U.S. cancer reg-
istries. Registration of NMSC in a few
diverse sentinel areas, therefore, would be
crucial for understanding future trends in
the incidence of NMSC, particularly in
view ofozone depletion and public health
campaigns for prevention and early detection
ofcancer.
Since NMSC is so common, morbidity
becomes a key component of its public
health impact. In individual cases, morbid-
ity ranges from quite minor to severe,
which can include the loss or impairment
ofvital facial structures such as eyes, ears,
or the nose. There is at present no pub-
lished method for assessing NMSC mor-
bidity among the general population,
although one is under development in our
unit. Use of morbidity data will become
increasingly important in the assessment of
the public health impact ofthis disorder.
Conclusions
Actual ultraviolet exposure received by the
general population is affected both by the
flux in the environment-which in turn is a
function ofstratospheric ozone depletion,
cloud cover, artificial cover, surface albedo,
altitude and latitude-and by behaviors of
the populations exposed. Significant progress
is being made in understanding how to
affect behaviors ofhigh risk populations,
but more accurate monitoring ofincidence,
morbidity, and mortality will be required to
assess the effects of these factors on the
public health burden from skin cancers.
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